Neuropsychopharmacology 2021
Top Research Directions
The 9 research directions with Neuropsychopharmacology 2021 papers, ranked by paper count, next to 2020. Share is the fraction of the edition’s papers in the direction.
| # | Direction | 2021 | 2020 | Share 2021 | Share 2020 | 2020 rank |
|---|---|---|---|---|---|---|
| 1 | Biological Subtyping to Parse Clinical Heterogeneity | 1 | 1 | 20.0% | 5.9% | 3 |
| 2 | Comparative Transcriptomics for Elucidating Cellular Mechanisms | 1 | 0 | 20.0% | 0.0% | — |
| 3 | Identifying Functional Gene Modules via Co-Expression Networks | 1 | 0 | 20.0% | 0.0% | — |
| 4 | Interpreting Gene Expression via Functional Enrichment Analysis | 1 | 0 | 20.0% | 0.0% | — |
| 5 | Master Regulator Discovery in Gene Regulatory Networks | 1 | 0 | 20.0% | 0.0% | — |
| 6 | Multi State Markov Models for Long Term Clinical Projections | 1 | 0 | 20.0% | 0.0% | — |
| 7 | Optimizing Predictive Lead Time for Proactive Clinical Intervention | 1 | 0 | 20.0% | 0.0% | — |
| 8 | The Discordance Between Transcript and Protein Expression | 1 | 0 | 20.0% | 0.0% | — |
| 9 | Unsupervised Discovery of Latent Clinical Phenotypes | 1 | 0 | 20.0% | 0.0% | — |
Download all directions as CSV
Institutions
Institutions credited by Neuropsychopharmacology 2021 papers: a paper credits every institution named in its affiliations, once. 10 institutions share 2 credited papers.
| # | Institution | Papers | Share | 2020 | 2020 rank |
|---|---|---|---|---|---|
| 1 | 01b3dvp57 | 1 | 50.0% | 0 | — |
| 2 | 033ztpr93 | 1 | 50.0% | 0 | — |
| 3 | Duke University | 1 | 50.0% | 0 | — |
| 4 | Max Planck Institute of Psychiatry | 1 | 50.0% | 0 | — |
| 5 | Mayo Clinic | 1 | 50.0% | 0 | — |
| 6 | National University of Singapore | 1 | 50.0% | 0 | — |
| 7 | The University of Texas Southwestern Medical Center | 1 | 50.0% | 0 | — |
| 8 | University of California, Irvine | 1 | 50.0% | 0 | — |
| 9 | University of Illinois Urbana-Champaign | 1 | 50.0% | 0 | — |
| 10 | Vanderbilt University | 1 | 50.0% | 1 | 20 |
Download all institutions as CSV
About this data
Papers. Neuropsychopharmacology 2021 lists 5 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.
Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2020 use shares, since the edition went from 17 to 5 papers.
Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 5 papers (40.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.
Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Neuropsychopharmacology 2021”, https://lacuna.tiptreesystems.com/venue/neuropsychopharmacology/2021.
Impactful Papers
Papers from Neuropsychopharmacology 2021 that shaped research clusters.